regorafenib tablets 40 mg
Regorafenib is a multi-kinase inhibitor that blocks several proteins responsible for cancer cell growth, the formation of new blood vessels that feed tumors (angiogenesis), and the maintenance of the tumor microenvironment.
Click to expand
Anti Cancer Tablets
regorafenib tablets 40 mg
By Natco Pharma Ltd.
₹8,000
WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
40 mg
Packaging
Typically available in a bottle of 28 tablets.
Type
Usually supplied in a High-Density Polyethylene (HDPE) bottle with a child-resistant cap or a box containing a bottle.
Shelf Life
24 to 36 months (2–3 years)
Regorafenib is a multi-kinase inhibitor that blocks several proteins responsible for cancer cell growth, the formation of new blood vessels that feed tumors (angiogenesis), and the maintenance of the tumor microenvironment.
Manufacturer Info
NameNatco Pharma Ltd.
PrescriptionPrescription-only (Rx).
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.